Infographic
Zydis® Orally Disintegrating Tablet (ODT) vs. Standard Tablets (ST)
Summary: This infographic provides a high level summary of studies comparing Zydis ODT against traditional oral tablets.
View Now
Webinars
High Potency Containment from Early Phase to Commercial Scale Micronization
Summary: In this webinar, learn more about enabling micronization of potent and highly potent compounds across the different stages of oral drug development
View Now
Executive Summary
Strategies for the Optimal Scale-up & Tech Transfer of Oral Small Molecules
Summary: Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success.
View Now
Article
Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays
Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or...
View Now
Webinars
Use of PBPK Modeling for Predicting and Optimizing Controlled Release Dosage Forms
Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.
View Now
Webinars
Strategies to Optimize the Dosage Form Design Process to Create Better Treatments
Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments.
View Now
Executive Summary
Developing Optimal Formulations
Summary: API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability.
View Now
Webinars
Integrated Approach to Spray Drying for Optimized Oral and Vaccine Formulations
Summary: In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery.
View Now
Video
Valuable Lessons for Pharmaceutical Manufacturing During a Pandemic
Summary: Catalent CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.
View Now
Webinars
Is My Molecule Suitable for an Orally Disintegrating Tablet?
Summary: This webinar aims to provide clarity on the types of molecules suitable for an ODT format as well as the regulatory pathways for new and established therapies.
View Now
